ANALYST-UPGRADE ·Filed Oct 7, 2026
Barclays initiates coverage on ABT at Overweight
Latest settled — T+5d
ABT ▲ +4.34% at T+5d
LONG call ✓ call won +4.34% · α vs SPY +5.32% · entry $98.69 → $102.97
Latest observation: T+7 +0.30% FF3 residual α
T+1d
-0.22%
call -0.22% · α +0.20%
$98.47
settled 11d ago
T+5d
+4.34%
call +4.34% · α +5.32%
$102.97
settled 5d ago
T+20d
—
call — · α —
—
in 16d
T+60d
—
call — · α —
—
in 3mo
Price Chart
Loading chart...
Executive Summary
Barclays initiates coverage on ABT at Overweight
Impact Score
Base Score
2/7
LLM Adjustment
+0
Final Score
4/10
Consensus & Targets
Buy / Strong Buy
25 (76%)
Hold
8
Sell / Strong Sell
0
Total Analysts
25
Mean PT
$120.74
Median PT
$120.00
High PT
$135.00
Low PT
$103.00
Current Price
$100.10
Implied Upside
+20.6%
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | initiate | Overweight | $120.00 |
| 2026-10-02 | Rothschild & Co | upgrade | Buy | $127.00 |
| 2026-10-02 | Rothschild& Co | upgrade | Buy | $127.00 |
| 2026-09-08 | TD Cowen | reiterate | Buy | $135.00 |
| 2026-08-25 | TD Cowen | maintain | Buy | — |
| 2026-08-21 | TD Cowen | maintain | Buy | $135.00 |
| 2026-08-14 | Citigroup | maintain | Buy | — |
| 2026-08-13 | Wolfe Research | upgrade | Outperform | $130.00 |
| 2026-07-28 | UBS | maintain | Buy | $125.00 |
| 2026-07-17 | Citigroup | maintain | Buy | $112.00 |
Firm Track Record — Barclays
Barclays accuracy: 54% on 6742 calls | avg return: 4%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Citigroup | 67% | 4/6 | 1.2% | top tier |
| Jefferies | 67% | 4/6 | 0.8% | top tier |
| Evercore ISI Group | 63% | 5/8 | 0.8% | top tier |
| RBC Capital | 56% | 5/9 | 1.8% | above average |
| Wells Fargo | 50% | 2/4 | -0.4% | below average |
| Goldman Sachs | 50% | 1/2 | 4.5% | below average |
| Barclays | 50% | 3/6 | 1.1% | below average |
| UBS | 50% | 1/2 | 1.3% | below average |
| Stifel | 50% | 1/2 | -0.9% | below average |
| BTIG | 40% | 2/5 | -3% | below average |
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $1.41 | $1.31 — $1.44 | $13.0B | ↑1 ↓0 |
| +1q | $1.64 | $1.59 — $1.67 | $13.5B | ↑1 ↓0 |
| 0y | $5.52 | $5.48 — $5.57 | $50.2B | ↑1 ↓0 |
| +1y | $6.07 | $5.88 — $6.20 | $54.5B | ↑1 ↓0 |
Cross-Platform Signals
Insider Trades (90d)
0 buys / 4 sells
Congressional
Rich McCormick (republican) — sell $1,001 - $15,000
Institutional
QRG CAPITAL MANAGEMENT, INC. — trim (-28.7%)
Institutional
Integrated Wealth Concepts LLC — add (40.2%)
Institutional
CITADEL ADVISORS LLC — doubled (348.7%)
Short Interest
Short: 1,760,231 | Exempt: 770 | TRF Vol: 2,940,648 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
24 reports for ABT
86% Hit rate best @ T+20▲ +17.16%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 11d ago | ANALYST-UPGRADE | $98.69 $102.97 | ▲ +4.34% | ▲ +5.32% | $104.89 (+6.29%) |
Oct 2, 2026 16d ago | ANALYST-UPGRADE | $97.50 $99.59 | ▲ +2.14% | ▲ +0.98% | $104.89 (+7.58%) |
Oct 2, 2026 16d ago | ANALYST-UPGRADE | $97.50 $99.59 | ▲ +2.14% | ▲ +0.98% | $104.89 (+7.58%) |
Sep 14, 2026 5w ago | Court Ruling | $103.09 $102.98 | ▼ −0.11% | ▼ −1.77% | $104.89 (+1.75%) |
Aug 11, 2026 9w ago | Court Ruling | $109.72 $112.68 | ▲ +2.70% | ▲ +3.10% | $104.89 (−4.40%) |
Aug 11, 2026 9w ago | Court Ruling | $109.72 $112.68 | ▲ +2.70% | ▲ +3.10% | $104.89 (−4.40%) |
Jul 31, 2026 11w ago | Institutional Cluster | $105.70 $107.81 | ▲ +2.00% | ▼ −1.51% | $104.89 (−0.77%) |
Jul 31, 2026 11w ago | Court Ruling | $105.70 $107.81 | ▲ +2.00% | ▼ −1.51% | $104.89 (−0.77%) |
Jul 24, 2026 12w ago | Court Ruling | $103.06 $105.61 | ▲ +2.47% | ▲ +2.10% | $104.89 (+1.78%) |
Jul 16, 2026 13w ago | 8-K | $98.83 $100.75 | ▲ +1.94% | ▲ +3.61% | $104.89 (+6.13%) |
Showing 10 of 24
US Market Status
Market Closed — Opens in 6h 35m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access